Sowell Financial Services LLC Uni Qure N.V. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$29.97 - $37.17 $7,672 - $9,515	-256 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$29.24 - $42.03 $526 - $756	-18 Reduced 6.57%	256 $8,000
Q4 2020 Jan 13, 2021	SELL	$35.35 - $50.67 $3,464 - $4,965	-98 Reduced 26.34%	274 $10,000
Q3 2020 Nov 12, 2020	SELL	$35.98 - $47.66 $14,176 - $18,778	-394 Reduced 51.44%	372 $14,000
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $49,926 - $75,055	-1,108 Reduced 59.12%	766 $35,000
Q1 2020 May 12, 2020	BUY	$40.01 - $73.97 $61,375 - $113,469	1,534 Added 451.18%	1,874 $89,000
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $13,382 - $26,112	340 New	340 $13,000

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.